💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

CNBC: Amazon in exploratory talks with generic-drug makers

Published 11/30/2017, 05:28 PM
Updated 12/01/2017, 12:00 AM
© Reuters.  CNBC: Amazon in exploratory talks with generic-drug makers
  • Amazon (NASDAQ:AMZN) has held preliminary talks with makers of generic drugs about its potential entry into the pharmacy space, CNBC reports.
  • The conversations, including with generics giants Mylan (NASDAQ:MYL) and Novartis (NYSE:NVS) unit Sandoz have been high-level, and the nature of AMZN's plans is not yet clear, but they may be about the company taking a role in drug purchasing, competing against distributors such as McKesson (NYSE:MCK), AmerisourceBergen (NYSE:ABC), and Cardinal Health (NYSE:CAH), according to the report.
  • Health care investment bank Leerink said in a note today that Sandoz' Peter Goldschmidt at a recent biopharma event "met and discussed with Amazon its plans for getting into the U.S. healthcare market," but it is not clear whether AMZN would enter as a drug wholesaler or sell generic medications as a retailer.
  • MYL +3.3% after-hours.
  • Now read: Cardinal Health: Wait For A Swing


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.